title: [Commercially available genomic-based signatures in early breast cancer: Is it ready for tomorrow morning?].
authors.affiliation: Département d'oncologie médicale, Institut Paoli-Calmettes, Marseille, France; Centre de recherche en cancérologie de Marseille, Inserm U1068, CNRS U7258, Aix-Marseille Université, France. Electronic address: goncalvesa@ipc.unicancer.fr.
authors.forename: Anthony
authors.initials: A
authors.lastname: Gonçalves
authors.affiliation: Département de pathologie et de biopathologie, Centre Jean-Perrin, 63011 Clermont-Ferrand cedex, France; EA 4677 Université d'Auvergne, Clermont-Ferrand, France.
authors.forename: Frédérique
authors.initials: F
authors.lastname: Penault-Llorca
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D003132:Commerce; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans
chemical_list: D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal